A US-Taiwan Business Council strategic report on the healthcare industry in Taiwan. The report examines outstanding regulatory and other matters in the pharmaceutical and medical device industries, and looks at potential future opportunities for U.S.-Taiwan bilateral cooperation within the healthcare sector.
Special Commentary: The US-Taiwan Business Council & U.S.-Taiwan Bilateral Relations in 2021 US-Taiwan Business Council activities in 2020 were severely curtailed due to the global COVID-19 pandemic. However, despite our inability to host in-person events or to travel to Taiwan, USTBC continued to offer engagement with our members and other relationships through virtual platforms. We […]
Council VP Lotta Danielsson argues that signing a high-standards and comprehensive bilateral U.S.-Taiwan trade agreement would have positive political implications and would help improve Taiwan’s regional economic integration.
(Arlington, Virginia and Taipei, Taiwan – September 15, 2020) The US-Taiwan Bilateral Trade Agreement Coalition launched on September 15, 2020. The Coalition will provide a mechanism for businesses and organizations across a wide range of sectors to express their support for negotiating and signing a Bilateral Trade Agreement (BTA) between the United States and […]
Testimony: The International Trade Administration: Comments Regarding Causes of Significant Trade Deficits for 2016 (Washington, D.C., May 10, 2017) Written Testimony by Lotta Danielsson Published by the US-Taiwan Business Council Introduction On March 31 2017, President Donald Trump signed Executive Order 13786, directing the Department of Commerce and the Office of the U.S. Trade Representative […]